Skip to content

Safety and efficacy evaluation of remazolam tosylate combined with esketamine in patients with endoscopic ligation of esophagogastric varices

Safety and efficacy evaluation of remazolam tosylate combined with esketamine in patients with endoscopic ligation of esophagogastric varices

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052235
Enrollment
Unknown
Registered
2021-10-23
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagogastric varices

Interventions

group A:Remazolam combined with esmketamine
group B:Propofol combined with esketamine
group C:Sevoflurane combined with esketamine

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) classification II-III; 2. The diagnostic criteria are in line with the ''Trial Plan for Standardized Endoscopic Diagnosis and Treatment of Digestive Tract Varicose Vein and Hemorrhage (2009)''; 3. The morphology of esophageal varices is grades GII to GIII; 4. Child-Pugh classification of liver function B-C; 5. Platelets > 50 x 10^9/L; 6. The diameter of varicose veins is 0.3-2cm.

Exclusion criteria

Exclusion criteria: 1. Upper gastrointestinal endoscopy is contraindicated; 2. Uncorrected hemorrhagic shock; 3. Portal cavernous degeneration; 4. Budd-Chiari syndrome; 5. Liver tumor; hepatic encephalopathy >= grade 2; 6. Severe cardiopulmonary and renal insufficiency; 7. Suffering from apnea syndrome; 8. Mental illness or receiving psychotropic medication; 9. Alcohol, opioid or sedative-hypnotic addiction; 10. Obesity (body mass index (BMI) > 30kg/m^2); 11. Allergic to the drugs used in the study; 12. For non-initial EVL, the operation time exceeds 40 minutes.

Design outcomes

Primary

MeasureTime frame
Number of remedies and total amount of drugs;

Secondary

MeasureTime frame
General information of patients;Perioperative hemodynamics;Intraoperative anesthetic dosage;Pain score;Operation time;Patient and physician satisfaction;Anesthesia time;Recovery time;Extubation time;

Countries

China

Contacts

Public ContactZhao Tonghang

Liaocheng People's Hospital

lbzthgn@163.com+86 13563557789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026